BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28353032)

  • 1. α-Synuclein Enhances Cadmium Uptake and Neurotoxicity via Oxidative Stress and Caspase Activated Cell Death Mechanisms in a Dopaminergic Cell Model of Parkinson's Disease.
    Chong W; Jiménez J; McIIvin M; Saito MA; Kwakye GF
    Neurotox Res; 2017 Aug; 32(2):231-246. PubMed ID: 28353032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms.
    Kwakye GF; Jiménez JA; Thomas MG; Kingsley BA; McIIvin M; Saito MA; Korley EM
    Neurotoxicology; 2019 Jan; 70():48-61. PubMed ID: 30399392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein attenuates 3-morpholinosydnonimine (SIN-1)-induced oxidative stress in dopaminergic neurons.
    Sharma SK; Ebadi M
    Antioxid Redox Signal; 2003 Jun; 5(3):251-64. PubMed ID: 12880480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease.
    Afeseh Ngwa H; Kanthasamy A; Anantharam V; Song C; Witte T; Houk R; Kanthasamy AG
    Toxicol Appl Pharmacol; 2009 Oct; 240(2):273-85. PubMed ID: 19646462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury.
    Sánchez Campos S; Alza NP; Salvador GA
    Arch Biochem Biophys; 2018 Oct; 655():43-54. PubMed ID: 30098984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
    Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R
    Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein overexpression enhances manganese-induced neurotoxicity through the NF-κB-mediated pathway.
    Prabhakaran K; Chapman GD; Gunasekar PG
    Toxicol Mech Methods; 2011 Jul; 21(6):435-43. PubMed ID: 21417633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
    Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
    Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S; Carlson EC; Swinscoe JC; Ebadi M
    J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferrin receptor iron and hydrogen peroxide.
    Kalivendi SV; Cunningham S; Kotamraju S; Joseph J; Hillard CJ; Kalyanaraman B
    J Biol Chem; 2004 Apr; 279(15):15240-7. PubMed ID: 14742448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
    Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG
    Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
    Kuter KZ; Śmiałowska M; Ossowska K
    Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa (L-DOPA) attenuates endoplasmic reticulum stress response and cell death signaling through DRD2 in SH-SY5Y neuronal cells under α-synuclein-induced toxicity.
    Song J; Kim BC; Nguyen DT; Samidurai M; Choi SM
    Neuroscience; 2017 Sep; 358():336-348. PubMed ID: 28687316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia.
    Nash Y; Schmukler E; Trudler D; Pinkas-Kramarski R; Frenkel D
    J Neurochem; 2017 Dec; 143(5):584-594. PubMed ID: 28921554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
    J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity.
    Li W; Lee MK
    J Neurochem; 2005 Jun; 93(6):1542-50. PubMed ID: 15935070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9).
    Daniel G; Musso A; Tsika E; Fiser A; Glauser L; Pletnikova O; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 Jan; 73():229-43. PubMed ID: 25461191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.
    Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J
    J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.